Evaluation of low dose alpha-interferon (Roferon-A®) in patients with advanced renal cell carcinoma: A Southwest Oncology Group Study

M. E. Marshall, M. Wolf, E. D. Crawford, I. M. Thompson, R. Flanigan, S. P. Balcerzak, Frederick J Meyers

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of low dose alpha-interferon (Roferon-A®) in patients with advanced renal cell carcinoma: A Southwest Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences